Virulence attributes of successful methicillin-resistant Staphylococcus aureus lineages
Clinical Microbiology Reviews · 20.12.2023 · 36 (4)
DOI: 10.1128/cmr.00148-22 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Microbiology Reviews, erschienen am 20.12.2023. Verfasst von Jhih-Hang Jiang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Infection Program, Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Community-Acquired Infections, Staphylococcal Infections. Die Arbeit wurde bisher 92-mal zitiert (Crossref) und nennt 600 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: DHAC | National Health and Medical Research Council (NHMRC).
Abstract (Originalsprache)
Methicillin-resistant Staphylococcus aureus (MRSA) is a leading cause of severe and often fatal infections. MRSA epidemics have occurred in waves, whereby a previously successful lineage has been replaced by a more fit and better adapted lineage. Selection pressures in both hospital and community settings are not uniform across the globe, which has resulted in geographically distinct epidemiology. This review focuses on the mechanisms that trigger the establishment and maintenance of current, dominant MRSA lineages across the globe. While the important role of antibiotic resistance will be mentioned throughout, factors which influence the capacity of S. aureus to colonize and cause disease within a host will be the primary focus of this review. We show that while MRSA possesses a diverse arsenal of toxins including alpha-toxin, the success of a lineage involves more than just producing toxins that damage the host. Success is often attributed to the acquisition or loss of genetic elements involved in colonization and niche adaptation such as the arginine catabolic mobile element, as well as the activity of regulatory systems, and shift metabolism accordingly (e.g., the accessory genome regulator, agr ). Understanding exactly how specific MRSA clones cause prolonged epidemics may reveal targets for therapies, whereby both core (e.g., the alpha toxin) and acquired virulence factors (e.g., the Panton-Valentine leukocidin) may be nullified using anti-virulence strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Infection Program, Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.
- Department of Infectious Diseases, The Alfred Hospital and Central Clinical School, Monash University, Melbourne, Victoria, Australia.
- Department of Biomedical Research, University of Bern, Bern, Switzerland.
- Laboratory of Molecular Genetics, Institutode Tecnologia Químicae Biológica António Xavier (ITQB-NOVA), Universidade Nova de Lisboa, Oeiras, Portugal.
- Escola Superior de Saúde da Cruz Vermelha Portuguesa-Lisboa (ESSCVP-Lisboa), Lisbon, Portugal.
- Centre to Impact Antimicrobial Resistance, Monash University, Clayton, Melbourne, Victoria, Australia.
ORCID-Profile: Jhih-Hang Jiang, Anton Y Peleg
Förderung
- DHAC | National Health and Medical Research Council (NHMRC)
Zitieren
APA
Jiang, J. H., Cameron, D. R., Nethercott, C., Aires-de-Sousa, M., & Peleg, A. Y. (2023). Virulence attributes of successful methicillin-resistant Staphylococcus aureus lineages. Clinical Microbiology Reviews, 36(4). https://doi.org/10.1128/cmr.00148-22
Vancouver
Jiang JH, Cameron DR, Nethercott C, Aires-de-Sousa M, Peleg AY. Virulence attributes of successful methicillin-resistant Staphylococcus aureus lineages. Clinical Microbiology Reviews. 2023;36(4). doi:10.1128/cmr.00148-22
BibTeX
@article{Jiang2023,
author = {Jiang, Jhih-Hang and Cameron, David R and Nethercott, Cara and Aires-de-Sousa, Marta and Peleg, Anton Y},
title = {Virulence attributes of successful methicillin-resistant Staphylococcus aureus lineages},
journal = {Clinical Microbiology Reviews},
year = {2023},
volume = {36},
number = {4},
doi = {10.1128/cmr.00148-22}
}
EUVIMED